Holding(s) in Company

RNS Number : 0137V

Allergy Therapeutics PLC

02 July 2009

 



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Allergy Therapeutics PLC

2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights		X
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):

3. Full name of person(s) subject to the notification obligation:	Highclere International Investors Ltd
4. Full name of shareholder(s) (if different from 3.):	The Highclere International Investors International Smaller Companies Fund The Highclere (Jersey) International Investors Smaller Companies Fund
5. Date of the transaction and date on which the threshold is crossed or reached:	1st July 2009
6. Date on which issuer notified:	1st July 2009
7. Threshold(s) that is/are crossed or reached:	Above 4%

8. Notified details:                                                              Not Applicable
A: Voting rights attached to shares
Class/type of shares if possible using the ISIN CODE	Situation previous to the triggering transaction		Resulting situation after the triggering transaction
	Number of Shares	Number of Voting Rights	Number of shares	Number of voting rights		% of voting rights
			Direct	Direct	Indirect	Direct	Indirect
ORDINARY	0	0	12,874,895	12,874,895		4.88%
GB00B022CQ05

B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument	Expiration date	Exercise/  Conversion  Period	Number of voting rights that may be acquired if the instrument is exercised/ converted.	% of voting rights
N/A	N/A	N/A	N/A	N/A

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument	Exercise  price	Expiration  date	Exercise/ Conversion  period	Number of voting  rights instrument  refers to	% of voting rights
					Nominal	Delta

Total (A+B+C)
Number of voting rights	Percentage of voting rights
12,874,895	4.88%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

Not Applicable

Proxy Voting:
10. Name of the proxy holder:	Highclere International Investors Ltd
11. Number of voting rights proxy holder will cease to hold:	Not Applicable
12. Date on which proxy holder will cease to hold voting rights:	Not Applicable

13. Additional information:	Highclere International Investors Ltd ("Highclere") acts as an investment manager for the clients detailed in Question 4 above (our "Clients"). In acting for our Clients, Highclere are given full discretion over their investments and are empowered to vote on their behalf. However, we do not act as our Clients’ custodian and therefore shares are not held in our name but in the nominee name of their custodian bank.
14. Contact name:	Fergus Gilmour, Compliance Officer
15. Contact telephone number:	0207-258-9845

 

END

 

 

HOLUUSRRKWRBRAR